Polaris Partners VII, L.P.
CIK 1611189 · last filed 2020-11-03
Polaris Partners VII, L.P. is a corporate insider who has filed 2 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for SQZ, was dated Nov 3, 2020. Across all open-market trades the lifetime net is +$21.0M, making them a net buyer over the disclosed history. The firm reports its address in Boston, MA. 10 SEC filings were submitted jointly with Polaris Management Co. VII, L.L.C.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
Filer Profile
10TH FLOOR
BOSTON, MA 02210
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SQZ Biotechnologies Co (SQZ) Delisted | 10%+ Owner | 2,315,652 | $0.43 | $1.01M | $12.00M | 1 | 2020-11-03 |
| Metacrine, Inc. (MTCR) Delisted | 10%+ Owner | 2,047,544 | $0.49 | $1.01M | $8.97M | 1 | 2020-09-22 |
Recent Filings
2 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-03 | SQZ Biotechnologies Co (SQZ) Delisted | Mixed | +8,182,938 | $12.00M | EDGAR |
| 2020-09-22 | Metacrine, Inc. (MTCR) Delisted | Mixed | +8,682,774 | $8.97M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.